Showing results (901-910 of 2,908) with videos related to

Sort By:
Pageof 291
Nature Communications|May 24, 2024
Heterogeneity in strategy use during arbitration between experiential and observational learningCaroline J Charpentier, Qianying Wu, Seokyoung Min, et al.
The Journal of Emergency Medicine|May 7, 2024
Association Between Frailty and Head Impact Location After Ground-Level Fall in Older AdultsXavier Dubucs, Éric Mercier, Valérie Boucher, et al.
Journal of Bacteriology|March 23, 2011
CRISPR distribution within the Escherichia coli species is not suggestive of immunity-associated diversifying selectionMarie Touchon, Sophie Charpentier, Olivier Clermont, et al.
Viruses|April 30, 2021
Survival Strategies of Streptococcus pyogenes in Response to Phage InfectionDior Beerens, Sandra Franch-Arroyo, Timothy J Sullivan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 12, 2006
Long-term results (10 years) of a prospective trial comparing Lo-tact-1 monoclonal antibody and anti-thymocyte globulin induction therapy in kidney transplantationS Beaudreuil, A Durrbach, J Noury, et al.
Urolithiasis|May 22, 2020
Derivation of a clinical predicting rule for obstructive urolithiasis and alternative diagnosis requiring urgent intervention: the CLAD scoreFrederic Balen, Marine Bastouil, Sandrine Charpentier, et al.
Chinese Medicine|May 31, 2011
The Yin and Yang actions of North American ginseng root in modulating the immune function of macrophagesChike Godwin Azike, Paul Abrahams Charpentier, Jirui Hou, et al.
Social Cognitive and Affective Neuroscience|November 22, 2015
Emotion-induced loss aversion and striatal-amygdala coupling in low-anxious individualsCaroline J Charpentier, Benedetto De Martino, Alena L Sim, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2018
Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavirElodie Alessandri-Gradt, Charlotte Charpentier, Marie Leoz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2B Escudier, F Farace, E Angevin, et al.
Pageof 291